Clinical trials: BA - Biliary Atresia
Liver Transplantation, Liver Diseases
Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation
The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation.
- Conditions
- Liver Transplantation, Liver Diseases, Biliary Atresia, Morbidity;Infant
- Trial name
- NCT04778735
- Testing
- Liver Transplantation
- Where
- Turkey (Türkiye)
- Volunteers
- 207 people
- Sponsor
- Memorial Bahçelievler Hospital
Biliary Atresia, Kasai Portoenterostomy Status
Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia
In this clinical study, meloxicam will be used to the patients who are older than 2 years and underwent Kasai portoenterostomy to treat their biliary atresia before.
- Trial name
- NCT02298218
- Testing
- Meloxicam
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Yonsei University
Granulocyte Colony-stimulating Factor, Biliary Atresia
Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia
The aim of the study is to evaluate the use of Granulocyte Colony Stimulating Factor (GCSF) on the clinical and biochemical outcome of type 3 biliary atresia post kasai.
- Trial name
- NCT06708572
- Testing
- Granulocyte Colony-Stimulating Factor
- Where
- Egypt
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- National Liver Institute, Egypt
Biliary Atresia
Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy
Abstract Biliary atresia (BA) is an idiopathic, progressive, and fatal disease if untreated. Since Kasai first introduced the operation for BA in 1959, there have been encouraging results in treating this disease.
- Trial name
- NCT00166868
- Testing
- Lactobacillus casei rhamnosus (Lcr35), Neomycin
- Where
- Taiwan
- Volunteers
- 30 people
- Sponsor
- National Taiwan University Hospital
Biliary Atresia
Kasai Portoenterostomy Timing and Outcomes in Biliary Atresia
What is this study about? This study aims to find out the best timing for a major surgery called Kasai portoenterostomy (Kasai surgery) in infants with a liver disease called biliary atresia.
- Trial name
- NCT07328204
- Testing
- Kasai portoenterostomy
- Where
- China
- Volunteers
- 200 people
- Sponsor
- The Children's Hospital of Zhejiang University School of Medicine
Biliary Atresia
Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy.
- Trial name
- NCT04336722
- Testing
- Odevixibat
- Where
- 72 sites in United States, Australia and 17 more
- Volunteers
- 254 people
- Sponsor
- Albireo, an Ipsen Company
to Find Out Non-invasive Indices to Predict the Status of Hepatic Fibrosis in BA Patients.
the Correlation Between Non-invasive Indicators in Patients With Biliary Atresia
we propose this study and try to find out possible clinical applicable non-invasive imaging indices or its combination with the laboratory indices to predict the status of hepatic fibrosis in BA patients.
- Trial name
- NCT02848573
- Volunteers
- 41 people
- Sponsor
- National Taiwan University Hospital
Biliary Atresia
Survival With Own Liver of Conventional Versus Laparoscopic Kasai for Biliary Atresia
This study evaluated laparoscopic (videosurgery) versus conventional (open surgery) Kasai portoenterostomy (anastomosis of small intestine to the liver hilus) in children with biliary atresia.
- Trial name
- NCT01063699
- Testing
- Laparoscopic Kasai operation
- Where
- Germany
- Volunteers
- 56 people
- Sponsor
- Hannover Medical School
Biliary Atresia
Efficacy of New Post Kasai ILBS Protocol in Biliary Atresia.
Biliary atresia (BA) is a neonatal progressive fibrosing cholan- giopathy and the most frequent indication for pediatric liver trans- plantation [1].
- Trial name
- NCT06447051
- Testing
- Kasai Surgery
- Where
- India
- Volunteers
- 100 people
- Sponsor
- Institute of Liver and Biliary Sciences, India
Biliary Atresia Congenital Type 3
A Peer Support Network System Construction for the Primary Caregivers of Children With Biliary Atresia
The peer support WeChat platform for primary caregivers of children with biliary atresia can provide social support ,help them adopt positive coping styles to face the disease, and reduce negative emotions and caregiver burden.
- Trial name
- NCT05503394
- Testing
- Peer support WeChat platform intervention, Routine nursing care group
- Where
- China
- Volunteers
- 45 people
- Sponsor
- Children's Hospital of Fudan University
Biliary Atresia, Metabolic Disorders
Clinical and Basic Study for Pediatric Liver Transplantation
Background: In mainland China, the development of pediatric liver transplantation (LT) has lagged behind that of adult LT during the past two decades, but it has been progressing immensely in recent years.
- Conditions
- Biliary Atresia, Metabolic Disorders, Fulminant Liver Failure, Hepatic Tumors
- Trial name
- CBSPLT (NCT02503384)
- Where
- China
- Volunteers
- 180 people
- Sponsor
- RenJi Hospital
Biliary Atresia
A Prospective Database of Infants With Cholestasis
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period.
- Trial name
- PROBE (NCT00061828)
- Where
- 16 sites in United States, Canada
- Volunteers
- 1,000 people
- Sponsor
- Arbor Research Collaborative for Health
Biliary Atresia
Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
The Investigators propose to test the hypothesis that GCSF enhances the clinical outcome of biliary atresia in a multi-institutional Phase 2 trial to prospectively evaluate the safety and efficacy of GCSF in each of the 2 groups…
- Trial name
- BA_GCSF2b (NCT04373941)
- Testing
- Filgrastim
- Where
- 4 sites in United States, Pakistan and 1 more
- Volunteers
- 400 people
- Sponsor
- Holterman, Ai-Xuan, M.D.
Biliary Atresia
RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.
Biliary atresia is a congenital disorder of bile duct development or destruction of established but immature bile ducts. The study tests the hypothesis that post-operative steroids improve outcome following the Kasai procedure …
- Trial name
- NCT00539565
- Testing
- prednisolone
- Where
- United Kingdom
- Volunteers
- 100 people
- Sponsor
- King's College Hospital NHS Trust
Cholestasis in Newborn, Biliary Atresia
The Dirty Nappy Study
This observational study evaluates whether a machine-learning algorithm, a computer program that learns patterns from data, can accurately diagnose cholestasis in newborns.
- Conditions
- Cholestasis in Newborn, Biliary Atresia, Neonatal Cholestasis
- Trial name
- NCT07697872
- Where
- United Kingdom
- Volunteers
- 5,350 people, healthy volunteers welcome
- Sponsor
- Birmingham Women's and Children's NHS Foundation Trust
BA - Biliary Atresia
Biliary Atresia With Rare Associations, a Case Report
Background: It is not often written in medical journals that preduodenal portal vein, biliary atresia, intestinal malrotation, and situs inversus totalis are all related.
- Trial name
- BA (NCT05917236)
- Testing
- hepato-portoentostomy
- Where
- Egypt
- Volunteers
- 1 people
- Sponsor
- Sarah Magdy Abdelmohsen
Biliary Atresia Intrahepatic Syndromic Form
Effects of Intraoperative Normal Saline vs Lactated Ringer on Outcomes in Pediatric Liver Transplantation
Lactated Ringer(LR) has been extensively used to maintain and replace intravascular volume in a variety of anesthetic procedures.
- Trial name
- NCT03563378
- Testing
- Lactated Ringer, Normal saline
- Where
- China
- Volunteers
- 200 people
- Sponsor
- RenJi Hospital
Biliary Atresia, Cholangitis
Definition for Biliary Atresia Associated Cholangitis After Surgery
Cholangitis is the most common postoperative complication of biliary atresia, with a reported incidence of 40-90%, which seriously affects the surgical effect, survival rate and the quality of life and prognosis of patients.
- Trial name
- NCT05464303
- Testing
- Intravenous Antibodies
- Where
- China
- Volunteers
- 500 people
- Sponsor
- Nanjing Children's Hospital